Central Nervous System Neoplasms
"Central Nervous System Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Benign and malignant neoplastic processes that arise from or secondarily involve the brain, spinal cord, or meninges.
| Descriptor ID |
D016543
|
| MeSH Number(s) |
C04.588.614.250 C10.551.240
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Central Nervous System Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Central Nervous System Neoplasms".
This graph shows the total number of publications written about "Central Nervous System Neoplasms" by people in this website by year, and whether "Central Nervous System Neoplasms" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 5 | 0 | 5 |
| 1996 | 5 | 1 | 6 |
| 1997 | 3 | 0 | 3 |
| 1998 | 5 | 1 | 6 |
| 1999 | 5 | 3 | 8 |
| 2000 | 4 | 1 | 5 |
| 2001 | 6 | 0 | 6 |
| 2002 | 10 | 0 | 10 |
| 2003 | 9 | 1 | 10 |
| 2004 | 8 | 3 | 11 |
| 2005 | 16 | 2 | 18 |
| 2006 | 15 | 2 | 17 |
| 2007 | 12 | 0 | 12 |
| 2008 | 11 | 4 | 15 |
| 2009 | 14 | 1 | 15 |
| 2010 | 15 | 2 | 17 |
| 2011 | 12 | 0 | 12 |
| 2012 | 11 | 1 | 12 |
| 2013 | 21 | 2 | 23 |
| 2014 | 19 | 2 | 21 |
| 2015 | 17 | 2 | 19 |
| 2016 | 16 | 2 | 18 |
| 2017 | 25 | 3 | 28 |
| 2018 | 11 | 6 | 17 |
| 2019 | 26 | 5 | 31 |
| 2020 | 24 | 2 | 26 |
| 2021 | 20 | 3 | 23 |
| 2022 | 22 | 0 | 22 |
| 2023 | 25 | 1 | 26 |
| 2024 | 15 | 3 | 18 |
| 2025 | 3 | 0 | 3 |
Below are the most recent publications written about "Central Nervous System Neoplasms" by people in Profiles.
-
Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions. Clin Cancer Res. 2025 Feb 03; 31(3):561-572.
-
Central nervous system tumors in adolescents and young adults: A Society for Neuro-Oncology Consensus Review on diagnosis, management, and future directions. Neuro Oncol. 2025 Jan 12; 27(1):13-32.
-
Low-Pass Whole Genome Sequencing of Cell-Free DNA from Cerebrospinal Fluid: A Focus on Pediatric Central Nervous System Tumors. Clin Chem. 2025 Jan 03; 71(1):87-96.
-
Evolving consolidation patterns and outcomes for a large cohort of patients with primary CNS lymphoma. Blood Adv. 2024 Dec 24; 8(24):6195-6206.
-
Targeted radionuclide therapy for patients with central nervous system metastasis: Overlooked potential? Neuro Oncol. 2024 Dec 09; 26(Supplement_9):S229-S241.
-
Clinicopathologic features of primary central nervous system anaplastic large cell lymphoma: a multicenter study identifies age and ALK status as prognostic factors. J Hematop. 2024 Dec; 17(4):215-222.
-
Outcomes and relapse patterns in primary central nervous system lymphoma: Longitudinal analysis of 559 patients diagnosed from 1983 to 2020. Neuro Oncol. 2024 Nov 04; 26(11):2061-2073.
-
A Phase 1 Study of ABI-009 (Nab-sirolimus) in Combination With Temozolomide and Irinotecan in Pediatric Patients With Recurrent or Refractory Solid Tumors, Including CNS Tumors-A Children's Oncology Group Pediatric Early Phase Clinical Trial Network Study ADVL1514. Cancer Med. 2024 Nov; 13(21):e70376.
-
Pediatric Central Nervous System Embryonal Tumors: Presentation, Diagnosis, Therapeutic Strategies, and Survivorship-A Review. Pediatr Neurol. 2024 Dec; 161:237-246.
-
CNS bridging radiotherapy achieves rapid cytoreduction before CAR T-cell therapy for aggressive B-cell lymphomas. Blood Adv. 2024 10 08; 8(19):5192-5199.